Literature DB >> 20830779

Long term G-CSF-induced remission of ulcerative colitis-like inflammatory bowel disease in a patient with glycogen storage disease Ib and evaluation of associated neutrophil function.

Abdulrahman Alsultan1, Ronald J Sokol, Mark A Lovell, Gail Thurman, Daniel R Ambruso.   

Abstract

We present a 23-year-old female with Glycogen storage disease Ib (GSD Ib) who was diagnosed with ulcerative colitis-like inflammatory bowel disease (IBD) at 7 years of age. G-CSF therapy reversed the IBD, was required to maintain IBD remission and was well tolerated. Neutrophil functions at time of diagnosis showed impaired chemotaxis but normal superoxide anion production and bactericidal activity. Ulcerative colitis-like IBD may also be seen in GSD Ib and is responsive to G-CSF therapy. Neutrophil dysfunction is variable among patients with GSD Ib.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20830779     DOI: 10.1002/pbc.22706

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  9 in total

Review 1.  Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease.

Authors:  Sergio Rutella; Franco Locatelli
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

Review 2.  Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Authors:  Kimihiko Oishi; Ronen Arnon; Melissa P Wasserstein; George A Diaz
Journal:  Pediatr Transplant       Date:  2016-06-21

Review 3.  New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation.

Authors:  Giorgos Bamias; Daniele Corridoni; Theresa T Pizarro; Fabio Cominelli
Journal:  Cytokine       Date:  2012-07-12       Impact factor: 3.861

4.  Inflammatory bowel disease (IBD)-like disease in a case of a 33-year old man with glycogenosis 1b.

Authors:  Magdalena Sarah Volz; Mani Nassir; Christoph Treese; Moritz von Winterfeld; Ursula Plöckinger; Hans-Jörg Epple; Britta Siegmund
Journal:  BMC Gastroenterol       Date:  2015-04-08       Impact factor: 3.067

5.  Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease.

Authors:  Margarita L Martinez-Fierro; Idalia Garza-Veloz; Maria R Rocha-Pizaña; Edith Cardenas-Vargas; Miguel A Cid-Baez; Fabiola Trejo-Vazquez; Virginia Flores-Morales; Gabriela A Villela-Ramirez; Ivan Delgado-Enciso; Iram P Rodriguez-Sanchez; Yolanda Ortiz-Castro
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

6.  Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort.

Authors:  Camille Wicker; Célina Roda; Ariane Perry; Jean Baptiste Arnoux; Anais Brassier; Martin Castelle; Aude Servais; Jean Donadieu; Juliette Bouchereau; Bénédicte Pigneur; Philippe Labrune; Frank M Ruemmele; Pascale de Lonlay
Journal:  Mol Genet Metab Rep       Date:  2020-04-09

7.  Cyclosporine modulates neutrophil functions via the SIRT6-HIF-1α-glycolysis axis to alleviate severe ulcerative colitis.

Authors:  Huiying Lu; Jian Lin; Chunjin Xu; Mingming Sun; Keqiang Zuo; Xiaoping Zhang; Mingsong Li; Hailiang Huang; Zhong Li; Wei Wu; Baisui Feng; Zhanju Liu
Journal:  Clin Transl Med       Date:  2021-02

8.  Rare complication of inflammatory bowel disease-like colitis from glycogen storage disease type 1b and its surgical management: A case report.

Authors:  Frederick Chi-Wai Lui; Oswens Siu-Hung Lo
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

9.  Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report.

Authors:  Alessandro Rossi; Erasmo Miele; Simona Fecarotta; Maria Veiga-da-Cunha; Massimo Martinelli; Carmine Mollica; Maria D'Armiento; Enza Mozzillo; Pietro Strisciuglio; Terry G J Derks; Annamaria Staiano; Giancarlo Parenti
Journal:  Ital J Pediatr       Date:  2021-07-02       Impact factor: 2.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.